A Massachusetts federal court has sentenced an Indian national to more than three years in prison after he admitted to conspiring with others to sell a counterfeit version of the cancer drug Keytruda, which contained none of the medication's life‑saving active ingredient, prosecutors said. The shocking case highlights the dangers of illicit drug supply networks and the potential harm to vulnerable patients.
The US Department of Justice (DOJ) announced that Sanjay Kumar, 45, of India, was sentenced to 43 months in prison followed by three years of supervised release after pleading guilty to one count of conspiracy to traffic in a counterfeit drug intended to treat advanced cancer.
